NIH-funded research R01 grant

Understanding how inflammation causes anemia in burn patients

Official title: Inflammatory Mechanisms in Post Burn Anemia of Critical Illness

Funded at University of Cincinnati · NIH-11010769 · Data updated 2026-11-12

This study is looking at why people with severe burns often have anemia, especially how inflammation might be making it harder for their bodies to produce red blood cells, and it aims to find new ways to help reduce the need for blood transfusions during their recovery.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Cincinnati
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startJanuary 1, 2022
Project endDecember 31, 2026
Funding year2025
Award (this year)$368,436
NIH project number5R01HL155579-04
Project IDNIH-11010769 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients who have experienced severe burns and are suffering from anemia as a result.

Less likely to help

Patients who do not have anemia or have not experienced severe burns may not benefit from this research.

What this research studies

This research investigates the causes of anemia in patients who have suffered severe burns, particularly focusing on how inflammation affects their blood production. The study aims to identify specific inflammatory mechanisms that lead to reduced red blood cell production and increased need for blood transfusions. By exploring the roles of certain signaling molecules in the body, the researchers hope to develop new treatments that could lessen the need for blood transfusions in these patients. This could ultimately improve recovery outcomes for burn victims in critical care settings.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that reduce the need for blood transfusions in burn patients, improving their recovery and overall health outcomes.

How similar studies have gone: Previous research has shown that understanding inflammatory mechanisms can lead to successful interventions in similar conditions, suggesting potential for success in this area as well.

Where this research is happening

  • University of Cincinnati
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Gardner, Jason — University of Cincinnati
  • Study coordinator: Gardner, Jason

Related research

Other NIH-funded projects on the same topics.

  • Anemia after severe burns

    Researchers are looking at how inflammation from severe burns causes anemia to find ways to reduce blood transfusions for burn patients.

    NIH research University of Cincinnati · Cincinnati, United States · NIH-11262815

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

  • Hydroxyurea for Children with Sickle Cell Disease in Africa

    A safe and feasible use of hydroxyurea for young children with sickle cell disease in several African countries to reduce illness and improve daily life.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606509

  • Glucocorticoids and critical illness outcomes in ICU patients

    A researcher team at Columbia University will study how glucocorticoids affect short- and long-term outcomes for people who survive critical illness, including mental health and recovery aspects.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11580346

  • Stem cell problems in Diamond-Blackfan anemia

    This project looks at why blood-forming stem cells don't work well in Diamond-Blackfan anemia by studying the common RPS19 gene change and its effects on TP53 and PRC2 pathways.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11481769

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.